TB drug: FDA approves Pretomanid Tablets, MSF says must be affordable
by News Desk from Outbreak News Today on (#4NB3W)
By NewsDesk @infectiousdiseasenews On Wednesday, the US Food and Drug Administration (FDA) approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. Pretomanid in combination with bedaquiline and linezolid is approved for treating a limited and specific population of adult patients with ["]
The post TB drug: FDA approves Pretomanid Tablets, MSF says must be affordable appeared first on Outbreak News Today.